The relationship between dose, route of administration, and clinical outcomes requires systematic investigation to establish therapeutic ranges and maximize efficacy while minimizing potential risks
CAS 685079-15-6 MW 159.21 g/mol Sequence Not listed Half-life Not listed Formula C10H11N2 Purity Certificate pending Form Lyophilized powder Class NNMT Inhibitor / Metabolic Research Compound The dossier
Free Radical Biology and Medicine, 93, 110117
doi: 10.3389/fneur.2026.1788148 Received 15 January 2026 Revised 16 February 2026 Accepted 23 February 2026 Published 07 April 2026 Volume 17 - 2026 Edited by Paul Chazot, Durham University, United Kingdom Reviewed by Li Baojian, Shaanxi University of Chinese Medicine, China Ayokunmi Akinduko, Landmark University, Nigeria Updates Copyright 2026 Okomolo Moto, Diapa Tchiengang, Kameni Njapdounke, Mbom, Mbeboh Savo, Aren Arsaa, Nezoumne, Ndjock and Bum
In SETD1B knockout cells, CHAC1 is not upregulated, preventing GSH depletion and conferring resistance to mycolactone-induced cytotoxicity (Figure 2) ( 3.6 Non-coding RNAs Non-coding RNAs (ncRNAs), encompassing long non-coding RNAs (lncRNAs) and microRNAs (miRNAs), play crucial roles in gene regulation without being translated into proteins
Ledda C, Cannizzaro E, Cin D, Filetti V, Vitale E, Paravizzini G, et al